Market Overview

The global pessary market was valued at USD 421.97 million in 2023 and is projected to expand steadily, reaching approximately USD 636.32 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period. Pessaries, non-invasive medical devices inserted into the vagina to support pelvic organs, have become a mainstay in the conservative management of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

As demand for less invasive and cost-effective treatment solutions increases, pessaries have emerged as a frontline option for women, particularly in aging populations and in regions where surgical interventions may be less accessible or desired. Advances in product design and material innovations, including the use of medical-grade silicone and customizable fit options, are driving adoption rates globally.

Key Market Growth Drivers

1. Rising Prevalence of Pelvic Organ Prolapse and Urinary Incontinence

The increasing incidence of pelvic floor disorders—especially among postmenopausal women—is a major driver for pessary adoption. POP affects a significant percentage of women worldwide, with many opting for non-surgical management due to its simplicity and fewer side effects. Similarly, the growing number of patients suffering from SUI is propelling demand for conservative therapies like pessary fittings.

2. Geriatric Population Growth

The world’s aging demographic is contributing heavily to the expansion of the pessary market. Older women are more susceptible to conditions such as prolapse and incontinence, and they often seek non-surgical treatments due to higher risks associated with operative procedures. This has fueled a consistent uptick in pessary prescriptions.

3. Shifting Preference Toward Minimally Invasive Solutions

Minimally invasive treatment options have become a strong global trend in healthcare. Pessaries offer an excellent alternative to surgical repair with fewer complications, reduced recovery times, and greater affordability. These benefits are gaining recognition among both healthcare providers and patients.

4. Increased Awareness and Accessibility

Public health initiatives, patient advocacy groups, and digital platforms have significantly raised awareness about female pelvic health. Education on treatment options, combined with a growing number of gynecologists and urologists recommending pessaries, has led to broader market penetration, especially in emerging economies.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/pessary-market 

Market Challenges

Despite its promising growth, the pessary market faces a few hurdles:

1. Lack of Awareness in Developing Regions

In several low- and middle-income countries, awareness about pelvic floor disorders and their management remains low. Cultural taboos and limited access to gynecological care further restrict adoption, particularly in rural or underserved areas.

2. Risk of Infections and Improper Usage

Improper fitting, delayed follow-up, or lack of hygiene may lead to complications such as vaginal infections, discharge, or ulcerations. These clinical concerns can deter both patients and physicians from opting for pessary use unless adequate training and guidance are ensured.

3. Availability of Alternative Treatments

With ongoing developments in pelvic reconstructive surgery and bioengineered meshes, patients and clinicians may sometimes opt for surgical solutions, especially in more severe cases or in settings where long-term pessary use is less preferred.

Market Segmentation

The pessary market can be segmented based on product type, application, and end user:

By Product Type:

• Ring Pessary (most widely used)

• Gellhorn Pessary

• Cube Pessary

• Donut Pessary

• Others

Ring pessaries dominate the market due to their simplicity, comfort, and ease of insertion and removal, especially for first-time users.

By Application:

• Pelvic Organ Prolapse

• Urinary Incontinence

Pelvic organ prolapse holds the largest share, with urinary incontinence gaining ground due to a growing recognition of the condition and available therapies.

By End User:

• Hospitals

• Gynecology Clinics

• Ambulatory Surgical Centers

• Homecare Settings

Gynecology clinics are the primary users due to specialized treatment options and follow-up facilities. However, homecare settings are emerging with the growing adoption of self-care pessary maintenance.

Regional Analysis

North America

North America accounts for the largest share of the global pessary market. A well-established healthcare system, high prevalence of POP and incontinence, and better awareness are contributing factors. The U.S., in particular, leads due to its aging population and higher patient engagement in pelvic health management.

Europe

Europe is another mature market, with countries like Germany, the UK, and France witnessing stable demand. Government-funded healthcare, comprehensive gynecological screening programs, and academic initiatives support the market.

Asia-Pacific

This region is poised for the fastest growth during the forecast period. Rising healthcare investments, urbanization, and a gradual shift in healthcare-seeking behavior are key drivers. China, India, and Japan are expected to lead growth, aided by increased awareness campaigns and better access to women’s healthcare services.

Latin America and Middle East & Africa

These regions are in the developing phase. However, the pessary market here is growing due to international aid programs, telemedicine advancements, and efforts to improve women's reproductive health services.

Key Companies & Competitive Insights

The pessary market is moderately consolidated, with several key players focusing on product innovation, distribution expansion, and clinical education. Companies are also investing in user-friendly designs and hypoallergenic materials to enhance patient experience and compliance.

Notable companies include:

• Bioteque America

• Bliss GVS Pharma

• CooperSurgical Inc.

• Dr. Arabin GmbH & Co. KG

• Integra LifeSciences

• MedGyn

• Panpac Medical Corporation

• Personal Medical Corporation

• Wallach Surgical Devices

These firms are actively involved in partnerships with healthcare providers, offering training modules and expanding distribution channels in emerging economies. Product approvals and CE marking are critical strategies to ensure global penetration.

Conclusion

The global pessary market is experiencing steady growth, supported by the increasing prevalence of pelvic organ disorders, demand for non-surgical treatment options, and broader healthcare accessibility. While challenges like patient education and potential side effects persist, the market holds strong promise, especially in developing regions.

With ongoing product innovation, investment in clinical training, and greater awareness, pessaries will continue to play a vital role in improving women’s health outcomes globally. The outlook remains positive for industry stakeholders looking to capitalize on this expanding segment of the women’s health device market.

More Trending Latest Reports By Polaris Market Research:

Nuclear Waste Management System Market

Peptide Based Cancer Therapeutics Market

automotive coatings market

Automated Material Handling Equipment Market

Lignin-Based Resins Market

E-Pharmacy Market

Recycled PET Flakes Market

Recycled PET Flakes Market

Automated Material Handling Equipment Market

Orphan Drugs Market

Rapid Oral Fluid Screening Devices Market

Synthetic Rubber Market

Small Drone Market

Neoprene Market

E-Pharmacy Market

Food Grade Gases Market

Food Grade Gases Market

Small Drone Market